Despite promise, Turing pharmaceuticals opts to keep list price of Daraprim high
November 25, 2015 at 17:07 PM EST
Doug G. Ware NEW YORK, Nov. 25 (UPI) -- Despite a pledge two months ago, Turing Pharmaceuticals said Wednesday it won't cut the list price of a drug used for infections associated with cancer and HIV.
